HK1135612A1 - Taste masking system for non-plasticizing drugs - Google Patents

Taste masking system for non-plasticizing drugs

Info

Publication number
HK1135612A1
HK1135612A1 HK10102128.9A HK10102128A HK1135612A1 HK 1135612 A1 HK1135612 A1 HK 1135612A1 HK 10102128 A HK10102128 A HK 10102128A HK 1135612 A1 HK1135612 A1 HK 1135612A1
Authority
HK
Hong Kong
Prior art keywords
taste masking
masking system
plasticizing drugs
usp
api
Prior art date
Application number
HK10102128.9A
Other languages
English (en)
Inventor
Walid Habib
Derek Moe
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of HK1135612A1 publication Critical patent/HK1135612A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10102128.9A 2005-01-06 2010-03-01 Taste masking system for non-plasticizing drugs HK1135612A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64180705P 2005-01-06 2005-01-06
US64261905P 2005-01-10 2005-01-10

Publications (1)

Publication Number Publication Date
HK1135612A1 true HK1135612A1 (en) 2010-06-11

Family

ID=36648121

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07113052.1A HK1107522A1 (en) 2005-01-06 2007-11-29 Taste masking system for non-plasticizing drugs
HK10102128.9A HK1135612A1 (en) 2005-01-06 2010-03-01 Taste masking system for non-plasticizing drugs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK07113052.1A HK1107522A1 (en) 2005-01-06 2007-11-29 Taste masking system for non-plasticizing drugs

Country Status (11)

Country Link
US (3) US20060147517A1 (xx)
EP (2) EP1830814B1 (xx)
JP (1) JP4995099B2 (xx)
AT (2) ATE435009T1 (xx)
CA (1) CA2593016C (xx)
DE (2) DE602006020642D1 (xx)
DK (1) DK1830814T3 (xx)
ES (1) ES2325599T3 (xx)
HK (2) HK1107522A1 (xx)
MX (1) MX2007008320A (xx)
WO (1) WO2006074185A2 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006020642D1 (de) * 2005-01-06 2011-04-21 Cima Labs Inc Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel
US20080124387A1 (en) * 2006-11-27 2008-05-29 Kapac, Llc Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
US8367115B2 (en) * 2007-08-27 2013-02-05 Asahi Kasei Chemicals Corporation Process for production of crystalline cellulose and tablets containing granules
US20100190739A1 (en) * 2008-12-15 2010-07-29 Fleming And Company, Pharmaceuticals Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
WO2012148432A1 (en) 2011-04-28 2012-11-01 Acme Specialty Products, Llc Taste masking compositions and edible forms thereof
EP3318247A1 (en) 2011-08-12 2018-05-09 Boehringer Ingelheim Vetmedica GmbH Taste masked pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE68916497T2 (de) * 1988-09-30 1994-11-17 Rhone Poulenc Rorer Ltd Pharmazeutisches Granulat.
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
KR20000069899A (ko) * 1997-01-06 2000-11-25 디. 제이. 우드, 스피겔 알렌 제이 속방성 및 미각 차폐성 약제학적 용량 형태
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
EP1688131A1 (en) * 1998-08-12 2006-08-09 Cima Labs Inc. Orally disintegratable tablet forming a viscous slurry
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
ES2601855T3 (es) * 1998-11-25 2017-02-16 Cima Labs Inc. Comprimido de liberación rápida con núcleo recubierto que contiene el fármaco y capa circundante de enmascaramiento del sabor
US6464632B1 (en) * 1999-02-13 2002-10-15 James M. Taylor Flexible inner liner for the working channel of an endoscope
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
ES2253364T3 (es) * 2000-03-28 2006-06-01 Farmarc Nederland B.V. Complejos de inclusion de alprazolam y sus composiciones farmaceuticas.
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US20030143272A1 (en) * 2001-03-14 2003-07-31 Waterman Kenneth C. Pharmaceutical tablet and process for making thereof
JP2004532257A (ja) * 2001-05-31 2004-10-21 シーマ・ラブス、インコーポレイテッド 高水溶性薬剤のテイスト・マスキング
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
WO2004022037A1 (en) * 2002-09-04 2004-03-18 Ranbaxy Laboratories Limited Taste masked dosage forms and processes for their preparation
JP2006515320A (ja) * 2002-12-31 2006-05-25 ラリー エル オーグスバーガー 活性クッション性成分を含有する医薬品剤形の製造方法
US20050232977A1 (en) * 2004-04-20 2005-10-20 Khan Sadath U Metered mixing technology for improved taste masking
DE602006020642D1 (de) * 2005-01-06 2011-04-21 Cima Labs Inc Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel

Also Published As

Publication number Publication date
WO2006074185A2 (en) 2006-07-13
CA2593016C (en) 2012-05-15
EP2098225B8 (en) 2011-06-22
JP2008526853A (ja) 2008-07-24
DK1830814T3 (da) 2009-08-03
US20060147517A1 (en) 2006-07-06
DE602006020642D1 (de) 2011-04-21
US20060147516A1 (en) 2006-07-06
US20150050336A1 (en) 2015-02-19
EP1830814A2 (en) 2007-09-12
HK1107522A1 (en) 2008-04-11
ES2325599T3 (es) 2009-09-09
ATE435009T1 (de) 2009-07-15
CA2593016A1 (en) 2006-07-13
EP2098225A3 (en) 2009-10-21
DE602006007538D1 (de) 2009-08-13
EP2098225A2 (en) 2009-09-09
ATE500822T1 (de) 2011-03-15
MX2007008320A (es) 2007-09-07
JP4995099B2 (ja) 2012-08-08
EP2098225B1 (en) 2011-03-09
EP1830814B1 (en) 2009-07-01
WO2006074185A3 (en) 2006-09-08
EP1830814A4 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
HK1135612A1 (en) Taste masking system for non-plasticizing drugs
NO20073802L (no) Leuprolidacetat og acetylkolinsteraseinhibitor eller NMDA-reseptorantagonister for behandlingen av Alzheimers sykdom
TW200716208A (en) Modified and immediate release memantine bead formulation
ES2659390T3 (es) Pastilla para chupar para uso en la reducción de la dependencia del tabaco y/o del alcohol
ATE474487T1 (de) Vorrichtung zur herstellung eines aufgebrühten aromatischen getränks
SG165373A1 (en) Oral dosage form comprising an antimisuse system
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
WO2007084221A3 (en) Methods and apparatus for identifying subject matter in view data
MY161079A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
EP2292220A3 (en) Composition and methods for increasing insulin sensitivity
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
TNSN08284A1 (en) Masking the taste of powders
EP3311801A3 (en) Chewable gelled emulsions
WO2008144061A3 (en) Novel combinations comprising a phosphodiesterase-5 inhibitor and their use
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
NZ599292A (en) Vitamin d compositions and method of administration to a human being
PT2205279E (pt) Associação farmacêutica de aliscireno e valsartan
UA102254C2 (ru) Жидкий состав для деферипрона с приятным вкусом
EP1262196A3 (en) Combination of a monoamine reuptake inhibitor and an opioid antagonist for use in alcoholism and alcohol dependence
HK1120417A1 (en) Stable nanoparticle formulations
HUP0102159A2 (hu) Készítmény savtúltengés kezelésére
MXPA05008902A (es) Soluciones de drogas en mentol.
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
WO2006023295A3 (en) Pharmaceutical compositions comprising effervescent agents and fenofibrate
MX2007004787A (es) Complejo que comprende mequitazina, una ciclodextrina y un agente de interaccion.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200110